nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allopurinol
|
|
|
2003 |
976 |
1 |
p. 6 |
artikel |
2 |
Antidepressants: FDA warns of paediatric suicide risk
|
|
|
2003 |
976 |
1 |
p. 2 |
artikel |
3 |
Aspirin does not impair survival in ACE inhibitor-treated CHF
|
|
|
2003 |
976 |
1 |
p. 3 |
artikel |
4 |
Betamethasone dipropionate/betamethasone valerate/mometasone
|
|
|
2003 |
976 |
1 |
p. 6 |
artikel |
5 |
Brimonidine
|
|
|
2003 |
976 |
1 |
p. 6-7 |
artikel |
6 |
Bupropion: chest pain does not seem to have a cardiac cause
|
|
|
2003 |
976 |
1 |
p. 5 |
artikel |
7 |
Calcium gluconate
|
|
|
2003 |
976 |
1 |
p. 7 |
artikel |
8 |
Casodex 150mg license withdrawn in UK for localised prostate cancer
|
|
|
2003 |
976 |
1 |
p. 2 |
artikel |
9 |
Ciprofibrate
|
|
|
2003 |
976 |
1 |
p. 7 |
artikel |
10 |
Cisatracurium besilate interaction
|
|
|
2003 |
976 |
1 |
p. 7 |
artikel |
11 |
Clofarabine
|
|
|
2003 |
976 |
1 |
p. 8 |
artikel |
12 |
Cotrimoxazole/enalapril/spironolactone
|
|
|
2003 |
976 |
1 |
p. 8 |
artikel |
13 |
Cyclizine
|
|
|
2003 |
976 |
1 |
p. 8 |
artikel |
14 |
Cyclosporin interaction
|
|
|
2003 |
976 |
1 |
p. 8-9 |
artikel |
15 |
Cyclosporin/methotrexate
|
|
|
2003 |
976 |
1 |
p. 9 |
artikel |
16 |
Cyclosporin/tacrolimus
|
|
|
2003 |
976 |
1 |
p. 9 |
artikel |
17 |
Dextran
|
|
|
2003 |
976 |
1 |
p. 9-10 |
artikel |
18 |
FDA notification: thrombosis and hypersensitivity with Cypher stent
|
|
|
2003 |
976 |
1 |
p. 2 |
artikel |
19 |
Fluconazole interaction
|
|
|
2003 |
976 |
1 |
p. 10 |
artikel |
20 |
Granulocyte colony-stimulating factor
|
|
|
2003 |
976 |
1 |
p. 10 |
artikel |
21 |
Haloperidol: tardive dyskinesia
|
|
|
2003 |
976 |
1 |
p. 5 |
artikel |
22 |
Hepatitis B vaccine
|
|
|
2003 |
976 |
1 |
p. 10 |
artikel |
23 |
Imatinib mesylate
|
|
|
2003 |
976 |
1 |
p. 10-11 |
artikel |
24 |
Immunosuppressants
|
|
|
2003 |
976 |
1 |
p. 11 |
artikel |
25 |
Indomethacin interaction
|
|
|
2003 |
976 |
1 |
p. 11 |
artikel |
26 |
Infliximab
|
|
|
2003 |
976 |
1 |
p. 11-12 |
artikel |
27 |
Interferon-α-2b
|
|
|
2003 |
976 |
1 |
p. 12 |
artikel |
28 |
Interferon-α-2b
|
|
|
2003 |
976 |
1 |
p. 12 |
artikel |
29 |
Levetiracetam
|
|
|
2003 |
976 |
1 |
p. 12-13 |
artikel |
30 |
Lithium/thioridazine
|
|
|
2003 |
976 |
1 |
p. 13 |
artikel |
31 |
Low molecular weight heparins: elevated serum potassium levels
|
|
|
2003 |
976 |
1 |
p. 5 |
artikel |
32 |
Metformin
|
|
|
2003 |
976 |
1 |
p. 13 |
artikel |
33 |
Minocycline
|
|
|
2003 |
976 |
1 |
p. 13 |
artikel |
34 |
Nitronaproxen better GI safety profile than naproxen
|
|
|
2003 |
976 |
1 |
p. 5 |
artikel |
35 |
Olanzapine
|
|
|
2003 |
976 |
1 |
p. 14 |
artikel |
36 |
Olanzapine/valproic acid/venlafaxine
|
|
|
2003 |
976 |
1 |
p. 14 |
artikel |
37 |
Paclitaxel
|
|
|
2003 |
976 |
1 |
p. 14 |
artikel |
38 |
Pantoprazole
|
|
|
2003 |
976 |
1 |
p. 14 |
artikel |
39 |
Parecoxib impairs endothelium-dependent vasodilation
|
|
|
2003 |
976 |
1 |
p. 3 |
artikel |
40 |
Phosphocreatine
|
|
|
2003 |
976 |
1 |
p. 15 |
artikel |
41 |
Pioglitazone
|
|
|
2003 |
976 |
1 |
p. 15 |
artikel |
42 |
Ramipril
|
|
|
2003 |
976 |
1 |
p. 15 |
artikel |
43 |
Reteplase/abciximab in MI: intracranial haemorrhage risk higher in elderly
|
|
|
2003 |
976 |
1 |
p. 5 |
artikel |
44 |
Rofecoxib
|
|
|
2003 |
976 |
1 |
p. 15-16 |
artikel |
45 |
Rofecoxib: fewer adverse GI events than naproxen
|
|
|
2003 |
976 |
1 |
p. 3 |
artikel |
46 |
Tacrolimus
|
|
|
2003 |
976 |
1 |
p. 16 |
artikel |
47 |
Tacrolimus
|
|
|
2003 |
976 |
1 |
p. 16 |
artikel |
48 |
Tacrolimus interaction
|
|
|
2003 |
976 |
1 |
p. 16 |
artikel |
49 |
Tamoxifen
|
|
|
2003 |
976 |
1 |
p. 17 |
artikel |
50 |
Tenofovir
|
|
|
2003 |
976 |
1 |
p. 17 |
artikel |
51 |
Thalidomide
|
|
|
2003 |
976 |
1 |
p. 17 |
artikel |
52 |
Thalidomide
|
|
|
2003 |
976 |
1 |
p. 17 |
artikel |
53 |
Thyroxine
|
|
|
2003 |
976 |
1 |
p. 18 |
artikel |
54 |
Vancomycin
|
|
|
2003 |
976 |
1 |
p. 18 |
artikel |
55 |
Ziprasidone
|
|
|
2003 |
976 |
1 |
p. 19 |
artikel |
56 |
Ziprasidone
|
|
|
2003 |
976 |
1 |
p. 18 |
artikel |